HALO logo
halo search icon
LKFT
Lakefront Biotherapeutics

LKFT · Lakefront Biotherapeutics

24.50

EUR
-0.28 (-1.13%)
24/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro1.63B

PE

5.80

EV/EBITDA

-2.2

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/07/2026 12:00:00 AM

Price Chart

Description

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

  • All-Companies
  • All-Consensus
  • Engulfing Bearish
  • Fakey Shakey - Short
  • HALO 100
  • HALO 50
  • HALO All
  • HALO Small

Key Fundamentals

EPS 3 yr Growth

-246.80%

EBITDA Margin

46.90%

Operating Cashflow

-€197m

Free Cash Flow Return

-6.40%

ROIC

10.40%

Interest Coverage

310.40

Quick Ratio

20.00

Performance

52 weeks range

Low 22.62 - 32.74

Trade Value (12mth)

US$667,647.00

1 week

-4.62%

1 month

-1.98%

YTD

-12%

1 year

-14.37%

All time high

252.90

Additional Data

Shares Outstanding (Fully Diluted)

69m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Lakefront Biotherapeutics (LKFT:BRU)?
Halo FAQ
The current share price of Lakefront Biotherapeutics (LKFT:BRU) is EUR€24.50.
2
What is the 52-week high share price for Lakefront Biotherapeutics (LKFT:BRU)?
Halo FAQ
The 52-week high share price for Lakefront Biotherapeutics (LKFT:BRU) is EUR€32.74.
3
What is the 52-week low share price for Lakefront Biotherapeutics (LKFT:BRU)?
Halo FAQ
The 52-week low share price for Lakefront Biotherapeutics (LKFT:BRU) is EUR€22.62.
4
What is the dividend yield for Lakefront Biotherapeutics (LKFT:BRU)?
Halo FAQ
Lakefront Biotherapeutics (LKFT:BRU) does not pay a dividend.
5
What was Lakefront Biotherapeutics (LKFT:BRU) last dividend payment?
Halo FAQ
Lakefront Biotherapeutics (LKFT:BRU) does not pay a dividend.
6
What is the franking level for Lakefront Biotherapeutics (LKFT:BRU)?
Halo FAQ
Lakefront Biotherapeutics (LKFT:BRU) has a franking level of 0.00%.
7
In which sector is Lakefront Biotherapeutics (LKFT:BRU) classified?
Halo FAQ
Lakefront Biotherapeutics (LKFT:BRU) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Lakefront Biotherapeutics (LKFT:BRU)?
Halo FAQ
The current P/E ratio for Lakefront Biotherapeutics (LKFT:BRU) is 5.80.